Open AccessJournal Article
Vessel Size and Long-Term Outcome After Coronary Stent Placement
ShpendElezi,AdnanKastrati,Franz-JosefNeumann,MartinHadamitzky,JosefDirschinger,AlbertSchömig +5 more
TLDR
The purpose of this study was to investigate the influence of vessel size on long-term clinical and angiographic outcome after coronary stent placement and identified subgroups with different risk for restenosis.Abstract:
Background—The role of coronary stenting in the treatment of patients with small vessels is not well defined. The purpose of this study was to investigate the influence of vessel size on long-term clinical and angiographic outcome after coronary stent placement. Methods and Results—The study comprised 2602 patients with successful stent implantation for symptomatic coronary artery disease. Patients were subdivided into 3 equally sized groups (tertiles) according to vessel size, with respective ranges of 3.2 mm. Event-free survival at 1 year was 69.5% in the group with smaller vessels, 77.5% in the second group, and 81% in the group with larger vessels (P<0.001). Late lumen loss was similar between the 3 groups (1.12±0.73, 1.12±0.79, and 1.09±0.88 mm, respectively). Angiographic restenosis rate was significantly higher in the small-vessel group (38.6%, 28.4%, and 20.4% in groups 1, 2, and 3, respectively; P<0.001). The analysis identified subgroups with different risk for restenosis ...read more
Citations
More filters
Journal ArticleDOI
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
Jeffrey W. Moses,Martin B. Leon,Jeffrey J. Popma,Peter J. Fitzgerald,David R. Holmes,Charles O'Shaughnessy,Ronald P. Caputo,Dean J. Kereiakes,David O. Williams,Paul S. Teirstein,Judith Jaeger,Richard E. Kuntz +11 more
TL;DR: In this randomized clinical trial involving patients with complex coronary lesions, the use of a sirolimus-eluting stent had a consistent treatment effect, reducing the rates of restenosis and associated clinical events in all subgroups analyzed.
Journal ArticleDOI
Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study.
Pedro A. Lemos,Angela Hoye,Dick Goedhart,Chourmouzios A. Arampatzis,Francesco Saia,Willem J. van der Giessen,Eugene P. McFadden,Georgios Sianos,Pieter C. Smits,Sjoerd H. Hofma,Pim J. de Feyter,Ron T. van Domburg,Patrick W. Serruys +12 more
TL;DR: Angiographic restenosis after SES implantation in complex patients is an infrequent event, occurring mainly in association with lesion-based characteristics and diabetes mellitus.
Journal ArticleDOI
Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO Study
Bernardo Cortese,Andrea Micheli,Andrea Picchi,Amelia Coppolaro,Loria Bandinelli,Silva Severi,Ugo Limbruno +6 more
TL;DR: Dior PCB failed to show equivalence to Taxus DES regarding angiographic end points during PCI of small coronary arteries and was compared to one of the most widely used DES.
Journal ArticleDOI
Drug-eluting stents: caution and concerns for long-term outcome.
TL;DR: Late stent thrombosis following CYPHERTM DES implantation is observed, with a hypersensitivity reaction around stent struts limited to the polymer with aneurysmal dilatation and extensive inflammation of the arterial wall in the absence of vascular healing.
Journal ArticleDOI
Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography.
TL;DR: The expected 6-month in-stent restenosis rate after stent implantation for short lesions in relatively large vessels can be predicted by use of in-Stent minimal area and stent length, both of which can be read from a simple reference chart.
References
More filters
Journal ArticleDOI
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
Jeffrey W. Moses,Martin B. Leon,Jeffrey J. Popma,Peter J. Fitzgerald,David R. Holmes,Charles O'Shaughnessy,Ronald P. Caputo,Dean J. Kereiakes,David O. Williams,Paul S. Teirstein,Judith Jaeger,Richard E. Kuntz +11 more
TL;DR: In this randomized clinical trial involving patients with complex coronary lesions, the use of a sirolimus-eluting stent had a consistent treatment effect, reducing the rates of restenosis and associated clinical events in all subgroups analyzed.
Journal ArticleDOI
Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study.
Pedro A. Lemos,Angela Hoye,Dick Goedhart,Chourmouzios A. Arampatzis,Francesco Saia,Willem J. van der Giessen,Eugene P. McFadden,Georgios Sianos,Pieter C. Smits,Sjoerd H. Hofma,Pim J. de Feyter,Ron T. van Domburg,Patrick W. Serruys +12 more
TL;DR: Angiographic restenosis after SES implantation in complex patients is an infrequent event, occurring mainly in association with lesion-based characteristics and diabetes mellitus.
Journal ArticleDOI
Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents
Adnan Kastrati,Alban Dibra,Julinda Mehilli,Sandra Mayer,Susanne Pinieck,Jürgen Pache,Josef Dirschinger,Albert Schömig +7 more
TL;DR: Vessel size and drug-eluting stent type are the most important predictors of angiographic and clinical restenosis, with drug-ElutingStent type having a particular impact on restenotic of small coronary vessels.
Journal ArticleDOI
Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO Study
Bernardo Cortese,Andrea Micheli,Andrea Picchi,Amelia Coppolaro,Loria Bandinelli,Silva Severi,Ugo Limbruno +6 more
TL;DR: Dior PCB failed to show equivalence to Taxus DES regarding angiographic end points during PCI of small coronary arteries and was compared to one of the most widely used DES.
Journal ArticleDOI
Drug-eluting stents: caution and concerns for long-term outcome.
TL;DR: Late stent thrombosis following CYPHERTM DES implantation is observed, with a hypersensitivity reaction around stent struts limited to the polymer with aneurysmal dilatation and extensive inflammation of the arterial wall in the absence of vascular healing.